Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Effect of Homeopathic Drugs Bellis Perennis ו- Staphysagria on the Post-operative Recovery, of Women Undergoing Cesarean Section- (an Exploratory) Double Blind, Placebo Controlled Study
Brief Summary: The planned study will be conducted in a prospective, randomized, double blind placebo controlled manner. Two "anti-traumatic" Homeopathic remedies (Arnica montana and Staphysagria) will be used. The selection of these remedies was based on a previous trial that showed a statistical difference in Hemoglobin levels favoring pregnant women treated with these drugs following delivery.

The proposed study will focus on the post-operative recovery of women undergoing Cesarean section. According to Homeopathic principles, these two remedies are believed to improve the "vital force", and will therefore improve convalescence following surgery in the study group. The study will include 90 women between the ages of 18 and 50 years who are scheduled for elective Cesarean Section. Exclusion criteria are: obesity (above 100kg), malignancy, psychiatric illness, diabetes and multipara pregnancies. Participants will be inducted following a detailed explanation by an MD and signing of an informed consent form, and then subdivided randomly into three groups numbering 30 in each: Two groups will be treated with homeopathic drugs of varied doses, and the third will get a placebo remedy which is indistinguishable from the other drugs. Outcome measures will include: 1. Blood loss - as estimated by a reduction in serum Hemoglobin levels. 2. Pain -to be evaluated by a numerical rating score (NRS) 3. Analgesic use 4. Length of post-operative stay and complications. 5. Quality of life outcomes - to be assessed using the MOS SF-36 questionnaire at one and four weeks following surgery. Although not expected, adverse events will be monitored.

If, as we anticipate, the homeopathic treatment proves to be both safe and effective in shortening the duration of post-operative healing, this will have significant implications, with respect to both healthcare costs and patient suffering. It will also open the door for further research in the field of trauma medicine, as well as other stress-related illness.


Options:
A: Arm Label: Active device; Type: ACTIVE_COMPARATOR; Interventions: Device: Pulsed electromagnetic field device (ActiPatch TM) | Arm Label: Placebo - inactive device; Type: PLACEBO_COMPARATOR; Interventions: Device: Inactive pulsed electromagnetic field device (ActiPatch TM) | Intervention Type: DEVICE; Name: Pulsed electromagnetic field device (ActiPatch TM); Assigned to Arm(s): Active device | Intervention Type: DEVICE; Name: Inactive pulsed electromagnetic field device (ActiPatch TM); Assigned to Arm(s): Placebo - inactive device
B: Arm Label: A; Type: ACTIVE_COMPARATOR; Interventions: Drug: Bellis perennis and Staphysagria (C6) | Arm Label: B; Type: ACTIVE_COMPARATOR; Interventions: Drug: Bellis perennis and Staphysagria (C30) | Arm Label: C; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Bellis perennis and Staphysagria (C6); Assigned to Arm(s): A | Intervention Type: DRUG; Name: Bellis perennis and Staphysagria (C30); Assigned to Arm(s): B | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): C
C: Arm Label: Primary Relief v 2.0 Device; Type: EXPERIMENTAL; Interventions: Device: Primary Relief v 2.0 | Arm Label: Paracetamol; Type: PLACEBO_COMPARATOR; Interventions: Drug: Paracetamol | Intervention Type: DEVICE; Name: Primary Relief v 2.0; Assigned to Arm(s): Primary Relief v 2.0 Device | Intervention Type: DRUG; Name: Paracetamol; Assigned to Arm(s): Paracetamol
D: Arm Label: Repeat C/S Control; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Repeat C/S Treatment; Type: ACTIVE_COMPARATOR; Interventions: Other: Alkantis | Arm Label: Primary C/S - Control; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Primary C/S Treatment; Type: ACTIVE_COMPARATOR; Interventions: Other: Alkantis | Intervention Type: OTHER; Name: Alkantis; Assigned to Arm(s): Primary C/S Treatment, Repeat C/S Treatment

Answer: B